OpenAlex
PricingAboutJobs
Log inGet started
Work

Abicipar pegol—a novel anti-VEGF therapy with a long duration of action

HTML PDF

Year: 2019
Type: editorial
Source: Eye
DOI: 10.1038/s41433-019-0584-y
Authors: Elad Moisseiev, Anat Loewenstein
Institutions: Tel Aviv University, Meir Medical Center, Tel Aviv Sourasky Medical Center
Language: English

Topic: Retinal Diseases and Treatments
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Keywords: anti-VEGF therapy, vascular endothelial growth factor, intravitreal injection, retinal disease, neovascular age-related macular degeneration, diabetic macular edema, retinal vein occlusion, duration of drug action
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W2973705051
Cites: 4
Cited by: 36
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security